Featured Editorial
When It Comes To Study Start-Up, The News Is Still Bad
By Ed Miseta, Chief Editor, Clinical Leader

The START II Study, conducted by Tufts CSDD and technology provider goBalto, attempted to determine how bad the study start-up process had become and how pharma could address the growing problem. It now takes six to seven months on average to perform study start-up. Despite new technologies making the start-up process easier, we still have 11 percent of sites that are never activated.

Take A Page From Amazon’s Playbook To Transform Clinical Trials
By Kenneth Wu

Around the holidays, I reminisce about family dinners: three generations under one roof for a few hours, catching up on the past year. My mother presided over the festivities for several decades until her passing. For 10 years, she was a survivor of a rare cancer. She had two surgical resections and treatments before the cancer returned. There was only one approved orphan drug, which was 50 percent effective in decreasing mortality for six months. There weren’t many options in clinical trials and no internet patient-centric community for information and support.

Industry Insights
Life Sciences And Serverless Tech: A Step Too Far?
Guest Column | By Jay Smith, TransPerfect

The special requirements that must be met as the cloud is adopted by life sciences organizations.

Top Considerations For EDC Vendor Selection
Guest Column | Medrio

How to be sure that the solution you’ve chosen is best suited to completing the task with speed and ease.

10 Steps To Better Alzheimer’s Disease Research
E-Book | Worldwide Clinical Trials

To date, advances in improving the lives of patients suffering from the ravages of Alzheimer's Disease (AD) and related dementias have been hard won, but research is at a tipping point. This CRO shares their 40 years of knowledge in Alzheimer's Disease research with steps on how to improve processes.

Enable Oral Delivery Of Synthetic Oligosaccharides
Case Study | Catalent

Due to their poor oral bioavailability, oligosaccharides are formulated as solutions or suspensions and delivered by invasive intravenous (IV) or subcutaneous injection.

Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.

Connect With Clinical Leader:
   LinkedIn    Twitter